Evercore ISI analyst Vijay Kumar added Avantor to the firm’s "Tactical Outperform" list as the firm made a number of changes to its lists as part of its Q1 earnings preview for the MedTech, Life Science Tools and Diagnostics group. Evercore has an Outperform rating and $28 price target on Avantor shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on AVTR: